QNZ was originally described as a potent inhibitor of NF-B activation (IC50 = 11 n) and TNF- production (IC50 = 7 nM).1,2 It indirectly inhibits the NF-B pathway via inhibition of store-operated calcium entry (SOC) and displayed neuroprotective effect
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten